I have been running semaglutide for three weeks and the honest summary is that the effect is smaller than the internet suggests and real.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
What the GLP-1 class does pharmacologically does not require the subjective effect to be large to be real.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Titration is slow by design and rushing it is how people end up miserable.
The interesting question is not whether it works but for whom and at what cost.
Test one thing at a time. It feels slower and it is the only way to learn anything.
What is the first thing you would read if you were starting from zero?
What is the first thing you would read if you were starting from zero? How long have you been on semaglutide?
Same here.
How long have you been on semaglutide?
Read methods.
How long before you can reasonably say something is or is not doing anything?
A plausible mechanism is not an outcome, and this class is the textbook example.
This is the kind of post the forum exists for.
Loose evidence and no evidence are different, and people overcorrect in both directions. Currently on semaglutide myself.
What is the first thing you would read if you were starting from zero?
Reconstitution arithmetic is only half the problem. The other half is what was in the vial.
Same here.
Same for me with semaglutide, unfortunately.
A certificate of analysis answers one question and gets quoted as though it answers four.
Baseline first.